Epidemiology and Clinical Features of Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Nonhospitalized Patients
Top Cited Papers
Open Access
- 1 March 2004
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 42 (3) , 1089-1094
- https://doi.org/10.1128/jcm.42.3.1089-1094.2004
Abstract
Infections due to extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (ESBLEC) in nonhospitalized patients seem to be emerging in different countries. Their incidence, epidemiology, and clinical impact in the community have not been studied. We describe the epidemiology and clinical features of infections caused by ESBLEC in nonhospitalized patients in Spain and the results of a case-control study performed to investigate the risk factors associated with the acquisition of these organisms. The clonal relatedness of the organisms was assessed by repetitive extragenic palindromic sequence PCR. The ESBLs and the genes encoding the ESBLs were initially characterized by isoelectric focusing and PCR, respectively. Forty-nine patients (76% with urinary tract infections, 22% with asymptomatic bacteriuria, and 2% with acute cholangitis) were included. Six patients were bacteremic. Diabetes mellitus (odds ratio, 5.5; 95% confidence interval, 1.6 to 18.7), previous fluoroquinolone use (odds ratio, 7.6; 95% confidence interval, 1.9 to 30.1), recurrent urinary tract infections (odds ratio, 4.5; 95% confidence interval, 1.3 to 15.1), a previous hospital admission (odds ratio, 18.2; 95% confidence interval, 5.3 to 61.1), and older age in male patients (odds ratio per year, 1.03; 95% confidence interval, 1.03 to 1.05) were identified as risk factors by multivariate analysis. The ESBLEC isolates were not clonally related. The ESBLs were characterized as members of the CTX-M-9 group, the SHV group, and the TEM group in 64, 18, and 18% of the isolates, respectively. ESBLEC is an emergent cause of urinary tract infections in nonhospitalized patients. There was no evidence of horizontal transmission of ESBLEC strains. Avoidance of fluoroquinolone use in high-risk patients should be considered whenever possible in order to avoid the selection of these organisms.Keywords
This publication has 32 references indexed in Scilit:
- Community-acquired multiresistant bacteria: an emerging problem?Journal of Hospital Infection, 2001
- Widespread Distribution of Urinary Tract Infections Caused by a Multidrug-ResistantEscherichia coliClonal GroupNew England Journal of Medicine, 2001
- Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance ThreatClinical Microbiology Reviews, 2001
- Antibiotic Susceptibility of Bacterial Strains Isolated from Patients with Community-Acquired Urinary Tract Infections in FranceEuropean Journal of Clinical Microbiology & Infectious Diseases, 2000
- Fatal Infection Due to Extended‐Spectrum Beta‐Lactamase‐Producing Escherichia coli: Implications for Antibiotic Choice for Spontaneous Bacterial PeritonitisClinical Infectious Diseases, 1999
- Piperacillin/Tazobactam in the Treatment ofKlebsiella PneumoniaeInfections in NeonatesAmerican Journal of Perinatology, 1998
- Effective cooling allows sonication to be used for liberation of β-lactamases from Gramnegative bacteriaJournal of Antimicrobial Chemotherapy, 1989
- CDC definitions for nosocomial infections, 1988American Journal of Infection Control, 1988
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- The Use of Analytical Isoelectric Focusing for Detection and Identification of -LactamasesJournal of General Microbiology, 1975